Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (191-200 of 268) with videos related to

Pageof 27
Sort By:
Clinical Pharmacology and Therapeutics|January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistanceD Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.
Cancer Surveys|January 1, 1993
Pharmacokinetics and early clinical studies of selected new drugsS B Kaye, P Workman, M A Graham, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor systemD J Honess, T H Wasserman, P Workman, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2004
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in miceN F Smith, A Hayes, B P Nutley, et al.
Anti-Cancer Drug Design|August 1, 1994
Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moietiesV G Brunton, M J Lear, D J Robins, et al.
Radiation Research|May 16, 2001
Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumorB M Seddon, D J Honess, B Vojnovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Estimation of plasma area under the curve for etanidazole (SR 2508) in toxicity prediction and dose adjustmentP Workman, R Ward, T S Maughan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in manP Workman, H F Newman, N M Bleehen, et al.
Anti-Cancer Drug Design|September 1, 1996
Synthesis and antiproliferative activity of tyrphostins containing quinoline moietiesV G Brunton, M J Lear, P McKeown, et al.
Biochemical Pharmacology|December 1, 1992
The enzymology of doxorubicin quinone reduction in tumour tissueJ Cummings, L Allan, N Willmott, et al.
Pageof 27

Showing results (191-200 of 268) with videos related to

Sort By:
Pageof 27
Clinical Pharmacology and Therapeutics|January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistanceD Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.
Cancer Surveys|January 1, 1993
Pharmacokinetics and early clinical studies of selected new drugsS B Kaye, P Workman, M A Graham, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor systemD J Honess, T H Wasserman, P Workman, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2004
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in miceN F Smith, A Hayes, B P Nutley, et al.
Anti-Cancer Drug Design|August 1, 1994
Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moietiesV G Brunton, M J Lear, D J Robins, et al.
Radiation Research|May 16, 2001
Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumorB M Seddon, D J Honess, B Vojnovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1989
Estimation of plasma area under the curve for etanidazole (SR 2508) in toxicity prediction and dose adjustmentP Workman, R Ward, T S Maughan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in manP Workman, H F Newman, N M Bleehen, et al.
Anti-Cancer Drug Design|September 1, 1996
Synthesis and antiproliferative activity of tyrphostins containing quinoline moietiesV G Brunton, M J Lear, P McKeown, et al.
Biochemical Pharmacology|December 1, 1992
The enzymology of doxorubicin quinone reduction in tumour tissueJ Cummings, L Allan, N Willmott, et al.
Pageof 27